OrthoPediatrics Q2 2024 Adj. EPS $(0.23) Beats $(0.27) Estimate, Sales $52.802M Beat $52.495M Estimate
Portfolio Pulse from Benzinga Newsdesk
OrthoPediatrics (NASDAQ:KIDS) reported Q2 2024 adjusted EPS of $(0.23), beating the estimate of $(0.27). Sales were $52.802M, surpassing the $52.495M estimate and marking a 33.48% increase from the same period last year.
August 05, 2024 | 8:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OrthoPediatrics reported better-than-expected Q2 2024 earnings and sales, with EPS of $(0.23) beating the $(0.27) estimate and sales of $52.802M surpassing the $52.495M estimate. Sales increased by 33.48% YoY.
The better-than-expected earnings and sales figures, along with a significant year-over-year sales increase, are likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100